439 related articles for article (PubMed ID: 21877891)
1. LC-MS/MS bioanalytical challenge: ultra-high sensitivity assays.
Aubry AF
Bioanalysis; 2011 Aug; 3(16):1819-25. PubMed ID: 21877891
[TBL] [Abstract][Full Text] [Related]
2. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
Hsieh Y
J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
[TBL] [Abstract][Full Text] [Related]
3. Reliable procedures to evaluate and repair crosstalk for bioanalytical MS/MS assays.
Morin LP; Mess JN; Furtado M; Garofolo F
Bioanalysis; 2011 Feb; 3(3):275-83. PubMed ID: 21320048
[TBL] [Abstract][Full Text] [Related]
4. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.
Van Eeckhaut A; Lanckmans K; Sarre S; Smolders I; Michotte Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2198-207. PubMed ID: 19179125
[TBL] [Abstract][Full Text] [Related]
5. A simplified protein precipitation/mixed-mode cation-exchange solid-phase extraction, followed by high-speed liquid chromatography/mass spectrometry, for the determination of a basic drug in human plasma.
Xue YJ; Akinsanya JB; Liu J; Unger SE
Rapid Commun Mass Spectrom; 2006; 20(18):2660-8. PubMed ID: 16912986
[TBL] [Abstract][Full Text] [Related]
6. Matrix effect elimination during LC-MS/MS bioanalytical method development.
Côté C; Bergeron A; Mess JN; Furtado M; Garofolo F
Bioanalysis; 2009 Oct; 1(7):1243-57. PubMed ID: 21083049
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive investigation of the influence of acidic, basic, and organic mobile phase compositions on bioanalytical assay sensitivity in positive ESI mode LC/MS/MS.
Rainville PD; Smith NW; Cowan D; Plumb RS
J Pharm Biomed Anal; 2012 Feb; 59():138-50. PubMed ID: 22088477
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
[TBL] [Abstract][Full Text] [Related]
9. Dodging matrix effects in liquid chromatography tandem mass spectrometric assays--compilation of key learnings and perspectives.
Srinivas NR
Biomed Chromatogr; 2009 May; 23(5):451-4. PubMed ID: 19101927
[TBL] [Abstract][Full Text] [Related]
10. Moving from fast to ballistic gradient in liquid chromatography/tandem mass spectrometry pharmaceutical bioanalysis: Matrix effect and chromatographic evaluations.
De Nardi C; Bonelli F
Rapid Commun Mass Spectrom; 2006; 20(18):2709-16. PubMed ID: 16921566
[TBL] [Abstract][Full Text] [Related]
11. A strategy for high-throughput analysis of levosimendan and its metabolites in human plasma samples using sequential negative and positive ionization liquid chromatography/tandem mass spectrometric detection.
Zhang J; Gage EM; Ji QC; El-Shourbagy TA
Rapid Commun Mass Spectrom; 2007; 21(14):2169-76. PubMed ID: 17631672
[TBL] [Abstract][Full Text] [Related]
12. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization.
Remane D; Meyer MR; Wissenbach DK; Maurer HH
Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3103-8. PubMed ID: 20941756
[TBL] [Abstract][Full Text] [Related]
13. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.
Ewles M; Goodwin L
Bioanalysis; 2011 Jun; 3(12):1379-97. PubMed ID: 21679032
[TBL] [Abstract][Full Text] [Related]
14. Using temperature to optimize resolution and reduce analysis times for bioanalytical diastereomer LC-MS/MS separations.
Cunliffe JM; Dreyer DP; Hayes RN; Clement RP; Shen JX
J Pharm Biomed Anal; 2011 Jan; 54(1):179-85. PubMed ID: 20837385
[TBL] [Abstract][Full Text] [Related]
15. 'LC-electrolyte effects' improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery.
Wang L; Sun Y; Du F; Niu W; Lu T; Kan J; Xu F; Yuan K; Qin T; Liu C; Li C
Rapid Commun Mass Spectrom; 2007; 21(16):2573-84. PubMed ID: 17639570
[TBL] [Abstract][Full Text] [Related]
16. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
Shou WZ; Zhang J
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
[TBL] [Abstract][Full Text] [Related]
17. Strategies for bioanalysis of an oligonucleotide class macromolecule from rat plasma using liquid chromatography-tandem mass spectrometry.
Zhang G; Lin J; Srinivasan K; Kavetskaia O; Duncan JN
Anal Chem; 2007 May; 79(9):3416-24. PubMed ID: 17394287
[TBL] [Abstract][Full Text] [Related]
18. A novel 'peak parking' strategy for ultra-performance liquid chromatography/tandem mass spectrometric detection for enhanced performance of bioanalytical assays.
Li F; Maguigad J; Pelzer M; Jiang X; Ji QC
Rapid Commun Mass Spectrom; 2008; 22(4):486-94. PubMed ID: 18215007
[TBL] [Abstract][Full Text] [Related]
19. Validating regulatory-compliant wide dynamic range bioanalytical assays using chip-based nanoelectrospray tandem mass spectrometry.
Wickremsinhe ER; Ackermann BL; Chaudhary AK
Rapid Commun Mass Spectrom; 2005; 19(1):47-56. PubMed ID: 15570573
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development.
Hsieh Y
Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
